FindTrial
Sign In

A clinical trial to study the efficacy of two drugs ( heat stable carbetocin versus oxytocin ) to minimize postpartum haemorrhage during labour.

Efficacy of heat stable carbetocin versus oxytocin to minimize postpartum haemorrhage during labour - A Randomized controlled Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097373
Enrollment
144
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Carbetocin: 100mg - single dose given Intra muscularly. Control Intervention1: Oxytocin: 10 IU- single dose given Intra muscularly.

Sponsors

Aarupadai Veedu medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Antenatal mothers more than 18 years who are undergoing delivery in AVMCH

Exclusion criteria

Exclusion criteria: 1.Mothers with hypertension /pre-eclampsia 2.Multiple pregnancy 3.Mothers with coagulation disorder 4.Mothers with CNS disorders 5.Mothers with liver or kidney disease 6.Hypersensitivity or contraindication to carbetocin/oxytocin

Design outcomes

Primary

MeasureTime frame
To study the effectiveness of Heat stable Carbetocin when compared to oxytocin to minimize blood loss thus preventing Post-partum Hemorrhage.Timepoint: 24 hours—

Secondary

MeasureTime frame
1.To compare the efficacy of heat stable Carbetocin & oxytocin to minimize blood loss during labour. 2. To study the side effects of Heat stable Carbetocin. Timepoint: 24 hours—

Countries

India

Contacts

Public ContactKeerthana S

Aarupadai Veedu Medical College and Hospital

deepa.shanmugam@avmc.edu.in8012081902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026